Endless schreef op 3 juni 2019 17:59:
Published: 17:45 CEST 03-06-2019 /GlobeNewswire /Source: Kiadis Pharma N. V. / : KDS /ISIN: NL0011323407
Kiadis Pharma to present at upcoming conferences in June 2019
Kiadis Pharma to present at upcoming conferences in
Amsterdam, The Netherlands, June 3, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company, today announces it is scheduled to attend the following conferences in June 2019.
Jefferies 2019 Global Healthcare Conference
June 4-7, 2019, New York, US
Management will present on June 4th at 4:00pm EDT and will host meetings with institutional investors.
European Hematology Association Conference
June 13-16, 2019, RAI Amsterdam, Europaplein 24, Amsterdam, The Netherlands
Dr Eduardo Olavarria (Kiadis and Imperial College London, UK) will present an abstract entitled "Phase 2 Study Evaluating The Safety And Efficacy Of One Or Two Doses Of Donor Lymphocytes Depleted Of Host Alloreactive T-cells (ATIR101) Following T-cell-depleted Haploidentical HSCT" on June 14th at 5:30pm CEST.